Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026
Tidepool, the nonprofit leader advancing innovation in diabetes technology, today unveiled new clinical insights and research initiatives in conjunction with the American Diabetes Association’s (ADA) 86th Scientific Sessions. The company’s presentation slate focuses on the immediate utility of real-world data and Tidepool’s ongoing commitment to closing gaps in women’s health research.
Today’s insights demonstrate sustained progress in the adoption of accessible, data-driven diabetes management, supporting both persons with diabetes and the clinicians who care for them.
Optimizing Resource-Limited Care: Helping Clinicians Prioritize Patient Engagement
Tidepool’s current ecosystem continues to yield critical insights for expanding remote, data-driven diabetes management in historically underserved communities.
